# TYENNE

NDC: 65219-590
Generic name: Tocilizumab-aazg
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20240415

FDA application: BLA761275

## Active ingredients

- TOCILIZUMAB: 80 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-590"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-590
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e400bbe6-43c5-4de6-82b9-cb44ce3cd906